Evidence map›Paper›PMID 33086555›Full record

ArticleAntioxidants (Basel, Switzerland)2020

Safety Evaluation of α-Lipoic Acid Supplementation: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Clinical Studies.

Federica Fogacci, Manfredi Rizzo, Christoffer Krogager, Cormac Kennedy, Coralie M G Georges, Tamara Knežević, Evangelos Liberopoulos, Alexandre Vallée, Pablo Pérez-Martínez, Eliane F E Wenstedt and 3 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06286098 (Effect of Alpha Lipoic Acid on the Clinical Outcome of Pediatric Patients Undergoing Hemodialysis), which is not on this map. Cited by 40 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 3 pooled it
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06286098 phase3enrolling by invitationnot on this mapstarted 2025, after this paper: background citation

Effect of Alpha Lipoic Acid on the Clinical Outcome of Pediatric Patients Undergoing Hemodialysis

TypeinterventionalSponsorAin Shams UniversityRan2025 to 2028Enrolled50ConditionsHemodialysis Complication, Pediatric Kidney Disease, Cardiovascular ComplicationArmsAlpha lipoic acid, Placebo
3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 3 syntheses or guidelines pooled it, 72 citations in OpenAlex.

  1. Pooled it
  2. Role of lipoic acid in multiple sclerosis.CNS neuroscience & therapeutics · 2022
    Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 12 institutions in 11 countries.

Federica FogacciHypertension and Cardiovascular Risk Factors Research Group, Medical and Surgical Sciences Department, Sant'Orsola-Malpighi University Hospital, 40138 Bologna, Italy.
Manfredi RizzoDepartment of Health Promotion Sciences Maternal and Infantile Care, Internal Medicine and Medical Specialities (PROMISE), School of Medicine, University of Palermo, 90127 Palermo, Italy.ORCID 0000-0002-9549-8504
Christoffer KrogagerDepartment of Endocrinology, Aarhus University Hospital, DK-8200 Aarhus N, Denmark.
Cormac KennedyDepartment of Pharmacology and Therapeutics, Trinity College Dublin and St James Hospital, Dublin 8, Ireland.
Coralie M G GeorgesDepartment of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, 1200 Brussels, Belgium.
Tamara KneževićDepartment of Nephrology, Hypertension, Dialysis and Transplantation, University Hospital Centre Zagreb, 10 000 Zagreb, Croatia.
Evangelos LiberopoulosSchool of Health Sciences, Faculty of Medicine, University of Ioannina, 451 10 Ioannina, Greece.ORCID 0000-0002-7162-3323
Alexandre ValléeDiagnosis and Therapeutic Center, Hôtel-Dieu Hospital, Paris-Descartes University, 75004 Paris, France.ORCID 0000-0001-9158-4467
Pablo Pérez-MartínezCIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28007 Madrid, Spain.
Eliane F E WenstedtAmsterdam UMC-University of Amsterdam, 1100 DD Amsterdam, The Netherlands.
Agnė ŠatrauskienėFaculty of Medicine, Vilnius University, LT-03101 Vilnius, Lithuania.
Michal VrablíkThird Department of Internal Medicine, First Medical Faculty, Charles University, 128 08 Prague 2, Czech Republic.
Arrigo F G CiceroHypertension and Cardiovascular Risk Factors Research Group, Medical and Surgical Sciences Department, Sant'Orsola-Malpighi University Hospital, 40138 Bologna, Italy.ORCID 0000-0002-4367-3884
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola · ITAarhus University Hospital · DKAmsterdam University Medical Centers · NLCharles University · CZCliniques Universitaires Saint-Luc · BEInstituto de Salud Carlos III · ESTrinity College Dublin · IEUniversité Paris Cité · FRUniversity Hospital Centre Zagreb · HRUniversity of Ioannina · GRUniversity of Palermo · ITVilnius University · LT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alpha-lipoic acid (ALA) is a natural short-chain fatty acid that has attracted great attention in recent years as an antioxidant molecule. However, some concerns have been recently raised regarding its safety profile. To address the issue, we aimed to assess ALA safety profile through a systematic review of the literature and a meta-analysis of the available randomized placebo-controlled clinical studies. The literature search included EMBASE, PubMed Medline, SCOPUS, Google Scholar, and ISI Web of Science by Clarivate databases up to 15th August 2020. Data were pooled from 71 clinical studies, comprising 155 treatment arms, which included 4749 subjects with 2558 subjects treated with ALA and 2294 assigned to placebo. A meta-analysis of extracted data suggested that supplementation with ALA was not associated with an increased risk of any treatment-emergent adverse event (all

Indexed as

dietary supplementmeta-analysissafetythioctic acidα-lipoic acid

Identifiers

PMID33086555
PMCPMC7603186
OpenAlexW3092656864

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.